-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

114.P1.60 114. Hemoglobinopathies, Excluding Thalassemia—Clinical: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, Biological, sickle cell disease, survivorship, Bleeding and Clotting, Diseases, Non-Biological, sickle cell trait, Therapies, Pediatric, red blood cells, Hemoglobinopathies, Pregnancy, Thrombosis, immune cells, Technology and Procedures, Young Adult, Cell Lineage, opioids, Study Population, Clinically relevant, palliative care, imaging, pharmacology, Quality Improvement , transfusion, transplantation
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Kristie Ramos, MD*, Amy E Mirro, MEng*, Michael M Binkley, PhD*, Luisa Gil Diaz*, Kristin P Guilliams, MD, MSCI*, Andria L Ford, MD, MSCI*, Hongyu An, DSc*, Jin-Moo Lee, MD, PhD* and Melanie E Fields, MD

Washington University in St. Louis, Saint Louis, MO

Elliott Vichinsky, MD1, Victor R. Gordeuk, MD2, Paul Telfer, DM, FRCP3*, Adlette Inati, MD, FAAP4, Margaret Tonda, PharmD5*, Sarah Gray, PhD5*, Irene Agodoa, MD5* and Kenneth I. Ataga, MD6

1UCSF Benioff Children's Hospital, Oakland, CA
2Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
3Barts Health NHS Trust, London, United Kingdom
4Lebanese American University, Beirut and Nini Hospital, Tripoli, Lebanon
5Global Blood Therapeutics, South San Francisco, CA
6University of Tennessee Health Science Center at Memphis, Memphis, TN

Wally R Smith, MD1, Kenneth I. Ataga, MD2, Santosh L. Saraf, MD3, Olufolake A. Adisa, MD, MSc4, Miranda Bailey5*, Nicholas Ramscar, MBBS6*, Ashley Bonner, PhD7*, Stephen Brown, PhD7* and Laura Pastor, MSc7*

1Virginia Commonwealth University, Richmond, VA
2University of Tennessee Health Science Center at Memphis, Memphis, TN
3Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
4Emory University, East Hanover, NJ
5Novartis Pharmaceuticals Corporation, East Hanover, NJ
6Novartis Pharma AG, Basel, Switzerland
7Eversana, Burlington, ON, Canada

Kristine Anne Karkoska, MD1, Kevin E Todd Jr., MD1, Kelly Clapp, NP2*, Lynette Fenchel, NP2*, Theodosia A. Kalfa, MD, PhD2, Punam Malik, MD2, Omar Niss, MD3, Charles T. Quinn, MD2, Russell E. Ware, MD, PhD2 and Patrick T. McGann, MD4

1Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3Division of Hematology, Cincinnati Children's Hospital, Cincinnati, OH
4Division of Hematology, Children's Hospital Medical Center, Cincinnati, OH

Elizabeth Williams, BA1, Elizabeth Linton, MPH2*, Rosalyn Stewart, MBA., MD, MS3*, Sophie M. Lanzkron, MD, MHS4 and Lydia H. Pecker, MD5

1West Virginia University School of Medicine, Morgantown, WV
2Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
3Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, MD
4Department of Medicine, Division of Hematology, Johns Hopkins Medicine, Baltimore, MD
5Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Abdoul Karim Dembele, MD1,2,3*, Patricia Hermand-Tournamille, PhD4*, Florence Missud, MD5*, Emmanuelle Lesprit, MD6*, Malika Benkerrou, MD7*, Yves Colin Aronovicz, PhD8,9, Caroline Le Van Kim, PhD2,10,11* and Bérengère Koehl, MD, PhD8,12,13,14*

1Laboratoire d’Excellence GR-Ex, Paris, France
2Université de Paris, UMR_S1134, BIGR, Inserm, F-75015, Paris, France
3Centre de Recherche et de Lutte contre la Drépanocytose (CRLD), Bamako, Mali
4University of Paris, INSERM UMR_S1134, BIGR, Institut National de Transfusion Sanguine, F-75015 Paris, France;, Paris, FRA
5Referral Center for Sickle Cell Disease, Robert Debré Hospital, Paris, France
6Etablissement Français du sang, Robert Debré Hospital, APHP, Paris, France
7Pediatrics, Referral Center for Sickle Cell Disease, Robert Debré Hospital, APHP, Paris, France
8Laboratory of Excellence GR-Ex, Paris, France
9UMR_S1134, Université de Paris/Inserm/INTS, Paris, France
10Laboratoire d'Excellence GrEx, Paris, France
11Institut National de la Transfusion Sanguine, F-75015, Paris, France
12Institut National de la Transfusion Sanguine, Paris, France
13UMR_S1134 Inserm/University Paris Diderot/INTS, Paris, France
14Reference Center of Sickle Cell Disease, Hopital Robert Debré, Paris, France

Rita V Masese, MSc, MD1*, Dominique Bulgin, BSN, RN2*, Liliana Preiss3*, Mitchell Knisely, PhD, RN1*, Eleanor Stevenson, PhD, RN1*, Jane S. Hankins, MD, MS4, Marsha Treadwell, PhD5,6*, Allison A. King, MD, MPH, PhD7, Victor R. Gordeuk, MD8, Julie Kanter, MD9, Robert Gibson, MD10*, Jeffrey A. Glassberg, MD11,12, Paula Tanabe, PhD, RN13 and Nirmish Shah, MD14

1School of Nursing, Duke University, Durham, NC
2Duke University School of Nursing, Durham, NC
3RTI International, Durham, NC
4Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
5Children's Hospital and Research Center, Oakland, Oakland, CA
6UCSF Benioff Children's Hospital Oakland, Oakland, CA
7Program in Occupational Therapy, Washington University in St. Louis, School of Medicine, Clayton, MO
8Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL
9Director, Adult Sickle Cell Program, Comprehensive Sickle Cell Center,, Birmingham, AL
10Medical College of Georgia, Augusta University, Augusta, GA
11Division of Hematology and Oncology, Department of Medicine and Department of Emergency Medicine, Mount Sinai Medical Center, New York, NY
12Division of Hematology Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
13School of Nursing/ School of Medicine, Duke University, Durham, NC
14Duke University Health System, Durham, NC

Raffaella Colombatti, MD, PhD1, John James, MSc2*, Biree Andemariam, MD3, Baba PD Inusa, MD, MBBS4, Fuad A El Rassi, MD5, Beverley Francis-Gibson, MA6*, Alecia C Nero, MD7*, Caterina P. Minniti, MD8, Cassandra Trimnell, BA9*, Miguel R Abboud, MD10, Jean-Benoît Arlet, MD11*, Mariane de Montalembert, MD, PhD12*, Suman Jain, MD13*, Wasil Jastaniah, MD14*, Erfan Nur, MD, PhD15, Marimilia Pita, MD16*, Nicholas Ramscar, MBBS17*, Tom Bailey, MSci18*, Olivera Rajkovic-Hooley, PhD18* and Ifeyinwa Osunkwo, MD, MPH19*

1Azienda Ospedale-Università di Padova, Padova, Italy
2Sickle Cell Society, London, United Kingdom
3New England Sickle Cell Institute at the University of Connecticut, Farmington, CT
4Evelina Children's Hospital and Guy’s and St Thomas’ Hospital, London, United Kingdom
5Emory University School of Medicine and Georgia Comprehensive Sickle Cell Center at Grady Health System, Atlanta, GA
6Sickle Cell Disease Association of America, Baltimore, MD
7University of Texas Southwestern Medical Center, Dallas, TX
8Albert Einstein College of Medicine, New York, NY
9Sickle Cell 101, San Jose, CA
10American University of Beirut Medical Center, Beirut, Lebanon
11Hôpital Européen Georges-Pompidou, Paris, France
12Hôpital Universitaire Necker-Enfants Malades, Paris, France
13Thalassemia and Sickle Cell Society, Hyderabad, India
14Umm Al-Qura University, Mecca, Saudi Arabia
15Academic Medical Center, Amsterdam, Netherlands
16Laureate University-UAM, Pediatric-Hematology, Hospital Samaritano, São Paulo, Brazil
17Novartis Pharma AG, Basel, Switzerland
18Adelphi Real World, Bollington, United Kingdom
19Sickle Cell Disease Enterprise at the Levine Cancer Institute/Atrium Health, Charlotte, NC

Wally R Smith, MD1, Jane S. Hankins, MD, MS2, Miguel R Abboud, MD3, Ze Cong, PhD4*, Jonathan Sorof, MD4*, Sarah Gray, PhD4*, Carolyn Hoppe, MD4* and Paul Telfer, DM, FRCP5*

1Virginia Commonwealth University, Richmond, VA
2Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
3American University of Beirut Medical Center, Beirut, Lebanon
4Global Blood Therapeutics, South San Francisco, CA
5Barts Health NHS Trust, London, United Kingdom

Khushali Jhaveri, MD1*, Raj Patel, MD2*, Christopher Barnett, MD1* and Hedy Smith, MD, PhD1

1Medstar Washington Hospital Center, Washington, DC
2Louis A Weiss Memorial Hospital, Chicago, IL

Seung Yup Lee1*, Eashani Sathilingam, BS1*, Kyle R. Cowdrick, MS1*, Rowan O. Brothers, BS1*, Wilbur A. Lam, MD, PhD1,2,3, R. Clark Brown, MD, PhD2,3, Clinton H. Joiner, MD, PhD2,3, Claudia R. Morris, MD3,4 and Erin M. Buckley, PhD1,3,4*

1Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA
2Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, Atlanta, GA
3Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
4Children's Healthcare of Atlanta, Atlanta, GA

Jordan Milner, MD1, Deborah Friedman, MD1*, Marise D’Souza, MD, MSc1*, Krishnan Sankaran, MD1*, Liana Klejmont, Pharm D1*, Erin Morris, RN, BSN1*, Harshini Mahanti, BS, MSCR1*, Neida Otero1*, Jessica C. Hochberg, MD1*, Adele Brudnicki, MD2*, Ken R. Cooke, MD3 and Mitchell S Cairo, MD1

1Pediatrics, New York Medical College, Valhalla, NY
2Radiology, New York Medical College, Valhalla, NY
3Oncology, John Hopkins University, Baltimore, MD

Satish Maharaj, MBBS, MD1, Simone Chang, MBBS1, Karan Seegobin, MBBS2, Marwan Shaikh, MD2 and Kamila I. Cisak, MD1

1University of Louisville, Louisville, KY
2Mayo Clinic, Jacksonville, FL

Kaitlin Strumph, DO1, Michael Hafeman, MD2*, Saritha Ranabothu, MD3*, William Gomes, MD4*, Steven Benitez, MD5*, Frederick Kaskel, MD6*, Deepa Manwani, MD7 and Joseph Mahgerefteh, MD8*

1Division of Pediatric Hematology/Oncology, Department of Pediatrics, Children's Hospital at Montefiore, Albert Einstein College of Medicine, New York, NY
2Department of Anesthesiology, Stony Brook University, Renaissance School of Medicine, Stony Brook, NY
3Department of Nephrology, Department of Pediatrics, Arkansas Children’s Hospital, Little Rock, AR
4Department of Radiology, Westchester Medical Center, Valhalla, NY
5Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
6Department of Nephrology, Department of Pediatrics, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY
7Division of Pediatric Hematology/Oncology, Department of Pediatrics, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY
8Division of Cardiology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, Kravis Children's Hospital, New York, NY

Ifeyinwa Osunkwo, MD, MPH1*, John James, MSc2*, Biree Andemariam, MD3, Fuad A El Rassi, MD4, Beverley Francis-Gibson, MA5*, Alecia C Nero, MD6*, Caterina P. Minniti, MD7, Cassandra Trimnell, BA8*, Miguel R Abboud, MD9, Jean-Benoît Arlet, MD10*, Raffaella Colombatti, MD, PhD11, Mariane de Montalembert, MD, PhD12*, Suman Jain, MD13*, Wasil Jastaniah, MD14*, Erfan Nur, MD, PhD15, Marimilia Pita, MD16*, Nicholas Ramscar, MBBS17*, Tom Bailey, MSci18*, Olivera Rajkovic-Hooley, PhD18* and Baba PD Inusa, MD, MBBS19

1Sickle Cell Disease Enterprise at The Levine Cancer Institute, Atrium Health, Charlotte, NC
2Sickle Cell Society, London, United Kingdom
3New England Sickle Cell Institute, University of Connecticut, Farmington, CT
4Emory University School of Medicine and Georgia Comprehensive Sickle Cell Center at Grady Health System, Atlanta, GA
5Sickle Cell Disease Association of America, Baltimore, MD
6University of Texas, Southwestern Medical Center, Dallas, TX
7Albert Einstein College of Medicine, New York, NY
8Sickle Cell 101, San Jose, CA
9American University of Beirut Medical Center, Beirut, Lebanon
10Hôpital Européen Georges-Pompidou, Paris, France
11Azienda Ospedale-Università di Padova, Padova, Italy
12Hôpital Universitaire Necker-Enfants Malades, Paris, France
13Thalassemia and Sickle Cell Society, Hyderabad, India
14Umm Al-Qura University, Mecca, Saudi Arabia
15Academic Medical Center, Amsterdam, Netherlands
16Laureate University-UAM, Pediatric-Hematology, Hospital Samaritano, São Paulo, Brazil
17Novartis Pharma AG, Basel, Switzerland
18Adelphi Real World, Bollington, United Kingdom
19Evelina Children's Hospital and Guy’s and St Thomas’ Hospital, London, United Kingdom

Cassondra Bour1*, Robert Emeh2*, Seyed Mehdi Nouraie, PhD, MD3, Nargues Weir, MD4*, Nicole Ruopp, MD5*, Amy Parker Ruhl, MD, MPH6* and Elizabeth S Klings, MD7

1Internal Medicine, Henry Ford Hospital, Detroit, MI
2Howard University College of Medicine, Washington DC, DC
3Division of Pulmonary, Allergy and Critical Care Medicine, UPMC Montefiore, Pittsburgh, PA
4Federal Drug Administration, Silver Spring, MD
5Brigham & Women's Hospital, Boston, MA
6National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
7Boston University Sch. of Med. The Pulmonary Center, R-304, Boston, MA

Almuhalb Ismail1* and Baba PD Inusa, MD, MBBS2,3

1King's college London, Women and children's academic unit, London, United Kingdom
2Paediatric Haematology, Evelina Children's Hospital, Guy's and St Thomas' Hospital, London, United Kingdom
3Department of Women and Children, King's College London, London, United Kingdom

Ameet Patel, MD1, Karina L Wilkerson, NP, MSN2*, Kathryn A. Culos, PharmD3*, Jennifer Green, MD4, Michael T. Byrne, DO5, Salyka M. Sengsayadeth, MD6*, Bhagirathbhai Dholaria, MBBS7,8, Bipin N. Savani, MD9,10, Stacey Ann Goodman, MD7,11, Wichai Chinratanalab, MD12, Reena Jayani, MD13, Katie S. Gatwood, PharmD3*, Brian G. Engelhardt, MD12 and Adetola A. Kassim, MD, MS12,14

1Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
2Hematology/Oncology Department Sickle Cell Disease Center of Excellence, Vanderbilt University Medical Center, Nashville, TN
3Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN
4Department of Hematology / Oncology, Vanderbilt University Medical Center, Nashville, TN
5Department of Medicine, Hematology and Stem Cell Transplant Section, Vanderbilt University Medical Center, Nashville, TN
6Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center; Tennessee Valley Health System Veterans Affairs Medical Center, Nashville, TN
7Vanderbilt University Medical Center, Nashville, TN
8Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical center, Nashville, TN
9Tennessee Valley Healthcare System Veteran Affairs, Nashville, TN
10Department of Medicine, Division of Hematology-Oncology, Vanderbilt University, Brentwood, TN
11VA Medical Center, Nashville, TN
12Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
13Vanderbilt University Medical Center, Tampa, FL
14Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Nashville, TN

Stephen Zachary Peeke, MD1,2, Qi Gao, Ph.D.3*, Jaeun Choi, PhD3*, Khadijah Abdallah, MPH4*, Ashley Buscetta, MSN, FNP-BC, CWOCN5*, Andrew Crouch6*, Shuo You, MD, PhD3*, Vence L. Bonham, JD7 and Caterina P. Minniti, MD8,9

1Maimonides Medical Center, Brooklyn
2Hematology/Oncology, Montefiore Medical Center, New York, NY
3Albert Einstein College of Medicine, Bronx, NY
4Social and Behavioral Research Branch, National Human Genome Research Institute/National Institutes of Health, Bethesda, MD
5Social and Behavioral Research Branch, National Human Genome Research Institute, Bethesda, MD
6Albert Einstein College of Medicine, Bronx
7National Human Genome Research Institute,Social and Behavioral Research Branch, NIH, Bethesda, MD
8Albert Einstein College of Medicine, New York, NY
9Montefiore Medical Center, Bronx, NY

*signifies non-member of ASH